We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
OLMESARTAN HCT ASTRON (Accord Healthcare Pty Ltd)
Product name
OLMESARTAN HCT ASTRON
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
181 (255 working days)
Active ingredients
Hydrochlorothiazide, Olmesartan medoxomil
Registration type
New generic medicine
Indication
Treatment of hypertension.
Treatment should not be initiated with this fixed dose combination.